CLINICAL_TRIALS
trial_result
· 2018-11-15
Clinical Trial Update: Effect of Konjac-mannan in Individuals With Insulin-Resistance Syndrome [Phase 2]
Summary
Phase 2 trial evaluating konjac-mannan in individuals with insulin resistance syndrome has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Unity Health Toronto | Conditions: Insulin Resistance Syndrome | Phase 2 | Status: COMPLETED